HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Armata Pharmaceuticals (AMEX: ARMP) and maintained a price target of $15 for the stock.